ConductScience.org, home

Paper508562

Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.

Workman P. Br J Cancer, 1979. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Papers, record 508562. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/508562

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
PubMed
Journal
Br J Cancer
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
3.13
iCite
Revised in PubMed
2019-05-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Workman PP

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MisonidazoleMajor topic
Neoplasms, ExperimentalMajor topic
NitroimidazolesMajor topic
PhenobarbitalMajor topic
PhenytoinMajor topic
Animals
Body Temperature
Body Weight
Brain
Drug Interactions
Half-Life
Lethal Dose 50
Liver
Male
Mice
Neoplasm Transplantation
Sleep
Transplantation, Homologous

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1589593Drug interactions with antineoplastic agents.Cancer Treat Rep1977https://conductscience.org/library/papers/589593PubMed
228921Differential effects of Walker 256 carcinosarcoma cells growing subcutaneously, intramuscularly, or intraperitoneally on hepatic microsomal mixed-function oxygenase activity.Drug Metab Dispos1978https://conductscience.org/library/papers/28921PubMed
3209809Peripheral neuropathy related to misonidazole: incidence and pathology.Br J Cancer Suppl1978https://conductscience.org/library/papers/209809PubMed
4413551In vitro studies with hexamethylmelamine.Biochem Pharmacol1977https://conductscience.org/library/papers/413551PubMed
595953In vivo studies with hexamethylmelamine.Eur J Cancer (1965)1978https://conductscience.org/library/papers/95953PubMed
6330116The use of nitroaromatic compounds as hypoxic cell radiosensitizers.Curr Top Radiat Res Q1977https://conductscience.org/library/papers/330116PubMed
7318924The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice.Cancer Res1977https://conductscience.org/library/papers/318924PubMed
8277210Sensitizing and toxicity properties of misonidazole and its derivatives.Br J Cancer Suppl1978https://conductscience.org/library/papers/277210PubMed
9273269Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.Radiat Res1978https://conductscience.org/library/papers/273269PubMed
10465300Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.Br J Cancer1979https://conductscience.org/library/papers/465300PubMed
11743488Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.Br J Cancer1978https://conductscience.org/library/papers/743488PubMed
12632143Differential cytotoxic effects of metronidazole and other nitro-heterocyclic drugs against hypoxic tumour cells.Int J Radiat Oncol Biol Phys1978https://conductscience.org/library/papers/632143PubMed
13927507Immunoprotection by embryonal carcinoma cells for methylcholanthrene-induced murine sarcomas.Nature1977https://conductscience.org/library/papers/927507PubMed
14861146Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.Br J Cancer1977https://conductscience.org/library/papers/861146PubMed
155752725Hepatic drug-metabolising enzyme activity and duration of hexobarbitone anaesthesia in barbitone-dependent and withdrawn rats.Biochem Pharmacol1968https://conductscience.org/library/papers/5752725PubMed
164383307Pharmacological implications of microsomal enzyme induction.Pharmacol Rev1967https://conductscience.org/library/papers/4383307PubMed
1755271Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.Br J Cancer1975https://conductscience.org/library/papers/55271PubMed
184647494Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.J Natl Cancer Inst1972https://conductscience.org/library/papers/4647494PubMed
191260835The cell proliferation kinetics of the EMT6/M/AC mouse tumour at four volumes during unperturbed growth in vivo.Cell Tissue Kinet1976https://conductscience.org/library/papers/1260835PubMed
205772752Studies on the metabolism of diphenylhydantoin in mice.J Pharmacol Exp Ther1969https://conductscience.org/library/papers/5772752PubMed

See all 21 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
7460192Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7460192PubMed
7387851Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.Br J Cancer1980https://conductscience.org/library/papers/7387851PubMed
7370170Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.Br J Cancer1980https://conductscience.org/library/papers/7370170PubMed
7370166Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.Br J Cancer1980https://conductscience.org/library/papers/7370166PubMed
7295516Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.Br J Cancer1981https://conductscience.org/library/papers/7295516PubMed
7273265Structure-pharmacokinetic relationships for misonidazole analogues in mice.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7273265PubMed
6849772No significant effect of metoclopramide on misonidazole elimination in man.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6849772PubMed
6824566An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.Br J Cancer1983https://conductscience.org/library/papers/6824566PubMed
6696821The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.Br J Cancer1984https://conductscience.org/library/papers/6696821PubMed
6481429Misonidazole neurotoxicity in rats: Part II. Effect of pre- and intermittent treatment with pentobarbital on misonidazole neurotoxicity in the rat.J Neurooncol1984https://conductscience.org/library/papers/6481429PubMed
6384434Metronidazole in the treatment of metastatic brain tumors. Results of a controlled clinical trial.J Neurooncol1984https://conductscience.org/library/papers/6384434PubMed
4085520Renal elimination of the hypoxic cell radiosensitizer misonidazole in Wistar rats: influence of some drugs on its excretion.Eur J Drug Metab Pharmacokinet1985https://conductscience.org/library/papers/4085520PubMed
3905334Importance of drug enantiomers in clinical pharmacology.Drugs1985https://conductscience.org/library/papers/3905334PubMed
3719893Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3719893PubMed
2736708Effects of elevated temperature on misonidazole O-demethylation by mouse liver microsomes: kinetic and stability studies of a model mixed-function oxidase reaction.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2736708PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/508562

GET https://conductscience.org/api/papers/v1/508562/references?page=2